Comparison Overview

Sint Maartenskliniek

VS

Cencora

Sint Maartenskliniek

Hengstdal 3 Nijmegen, 6522 JV, NL
Last Update: 2025-03-14 (UTC)

Strong

Bij de Sint Maartenskliniek draait alles om de menselijke beweging. Als gespecialiseerd ziekenhuis zijn we in Nederland en Europa toonaangevend in de behandeling van aandoeningen op het gebied van houding en beweging. We staan bekend om onze aanpak van complexe aandoeningen. Maar u kunt ook bij ons terecht voor veelvoorkomende klachten of blessures op het gebied van orthopedie, reumatologie, revalidatiegeneeskunde en pijnbestrijding. We bieden behandelingen en zorg aan op verschillende locaties in Nederland: in Nijmegen, Woerden en Boxmeer.

NAICS: 62
NAICS Definition:
Employees: 1,001-5,000
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Cencora

None
Last Update: 2025-07-24 (UTC)

Excellent

Between 900 and 1000

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, weโ€™re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 51,000 worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $290 billion in annual revenue.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 26,508
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sint-maartenskliniek.jpeg
Sint Maartenskliniek
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/cencoraglobal.jpeg
Cencora
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
Sint Maartenskliniek
100%
Compliance Rate
0/4 Standards Verified
Cencora
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Sint Maartenskliniek in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Cencora in 2025.

Incident History โ€” Sint Maartenskliniek (X = Date, Y = Severity)

Sint Maartenskliniek cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Cencora (X = Date, Y = Severity)

Cencora cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sint-maartenskliniek.jpeg
Sint Maartenskliniek
Incidents

No Incident

https://images.rankiteo.com/companyimages/cencoraglobal.jpeg
Cencora
Incidents

No Incident

FAQ

Cencora company company demonstrates a stronger AI risk posture compared to Sint Maartenskliniek company company, reflecting its advanced AI governance and monitoring frameworks.

Historically, Cencora company has disclosed a higher number of cyber incidents compared to Sint Maartenskliniek company.

In the current year, Cencora company and Sint Maartenskliniek company have not reported any cyber incidents.

Neither Cencora company nor Sint Maartenskliniek company has reported experiencing a ransomware attack publicly.

Neither Cencora company nor Sint Maartenskliniek company has reported experiencing a data breach publicly.

Neither Cencora company nor Sint Maartenskliniek company has reported experiencing targeted cyberattacks publicly.

Neither Sint Maartenskliniek company nor Cencora company has reported experiencing or disclosing vulnerabilities publicly.

Neither Sint Maartenskliniek company nor Cencora company has publicly disclosed detailed information about the number of their subsidiaries.

Cencora company employs more people globally than Sint Maartenskliniek company, reflecting its scale as a Hospitals and Health Care.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X